Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-05-10
2005-05-10
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388850, C530S391300, C424S133100, C424S156100
Reexamination Certificate
active
06891023
ABSTRACT:
Novel recombinant antibodies from murine antibody IOR C5 produced by the hybridoma deposited with the ECCC 97061101. The recombinant antibodies were obtained using recombinant DNA technology and are characterized in that they recognize antigen ior C2. The recombinant antibodies are specifically chimeric antibody, humanized antibody, and single chain Fv fragment. The chimeric antibody contains the variable domains of the murine immunoglobuline and the constant regions of the human immunoglobuline. The humanized antibody contains the constant regions of human immunoglobuline and has been specifically modified in the murine frameworks regions (FRs) and within the latter, in those areas that may result in an antigenic site for cells T. The Fv fragment contains the variable domains of murine immunoglobuline. The invention also relates to the utilization of recombinant antibodies derived from murine antibody ior C5 in the diagnosis and therapy of colorectal tumors, the metastasis thereof and recurrences.
REFERENCES:
patent: 5712120 (1998-01-01), Rodriguez et al.
patent: WO 9109967 (1991-07-01), None
patent: WO9733196 (1997-09-01), None
Paul fundamental Immunolgy, Raven Press, chapter 8, p. 242, 1993.*
Panka et al PNAS 85:3080-84, 1988.*
Amit et al Science 233:747, 1986.*
Rudikoff et al PNAS 79:1979-1983, 1982.*
Bird et al Science 242:423, 1988.*
Riechmann et al Nature 332:323,1988.*
Immunologia 14: 130-132, 1995, Characterization of IOR C5 Colorectal Tumor Associated Antigen, Vazques et al.
Nature vol. 332, pp. 323-327, Reshaping Human Antibodies for Therapy, 1988, Jongs et al.
Ávila Marta Ayala
Calzado Enrique Rengifo
Cowley Jorge Victor Gavilondo
de Acosta Del Rio Cristina Maria Mateo
Escobar Normando Iznaga
Centro Inmunologia Molecular
Helms Larry R.
Lackenbach & Siegel LLP
LandOfFree
Antibodies and Fv fragment recognizing antigen IOR C2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies and Fv fragment recognizing antigen IOR C2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies and Fv fragment recognizing antigen IOR C2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3374490